Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer

J Clin Oncol. 2023 Aug 1;41(22):3873-3874. doi: 10.1200/JCO.23.00686. Epub 2023 May 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists / adverse effects
  • Docetaxel / therapeutic use
  • Hormones / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms* / pathology

Substances

  • Docetaxel
  • Hormones
  • Androgen Antagonists